Questions remain as Valeant plays defense

Oct 26, 2015, 07:07 PM

Headliner
Share
Subscribe

The Moneybeat crew attempts to answer looming questions that remain after Valeant Pharmaceuticals attempts to defend itself.

Share
Subscribe
Next
Halloween Indicator, more treat than trick for you
Top episodes
How Printing Fake Money Helped People Manage Their Cash
by WSJ Your Money Matters
Where to Put Your Cash if the Fed Lowers Interest Rates
by WSJ Your Money Matters
How to Get Out of Debt
by WSJ Your Money Matters